Research On The Model Of Backdoor Listing

Analysis of CGA luomei pharmaceutical backdoor listing case,through the review of the related theories and Research on the backdoor listing,the capital market of our country enterprise backdoor listing mode is analyzed,and a detailed analysis of the CGA luomei listed the specific characteristics of phanrmaceutical backdoor.The analysis of the background,motivation,schemes and characteristics of CGA luomei listed pharmaceutical backdoor,a better understanding of the backdoor listing mode,and through the case in question,can understand the existing problems of backdoor listing mode.Combined with the case,the paper analyzes the revision of the management measures of the listed company's major asset restructuring,and considers the reasons for the formulation of the new regulations,which is helpful to understand the direction of the future development of mergers and acquisitions.This paper uses the methods of literature research and case analysis,analysis and Research on typical cases of CGA luomei pharmaceutical listed backdoor,described and analyzed from the main mode of simple concept,backdoor listing on the aspects of the model,a comprehensive analysis of the existing CGA luomei problems in pharmaceutical backdoor listing,shell selection,focus on the market net assets into the shell,and set out and subsequent placement and liquidity premium compensation.Further clarify the problems in the backdoor listing model.Finally,according,to the CGA luomei pharmaceutical backdoor listing case,further to the multilevel equity market construction,supervision of listed companies backdoor backdoor backdoor behavior.Related laws and regulations,market intermediaries constraint mechanism construction and other aspects put forward effective suggestions,summarize the experience and Enlightenment from the listing mode and in the process of backdoor backdoor backdoor listing,provide some reference for other enterprises.